{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["7(15)"],"submitter":["Li T"],"pubmed_abstract":["<h4>Purpose</h4>Pregnane x receptor (PXR) - activated overexpression of the multidrug resistance 1 (MDR1) gene is an important way for tumor cells to acquire drug resistance. However, the detailed mechanism still remains unclear. In the present study, we aimed to investigate whether protein arginine methyl transferase 1(PRMT1) is involved in PXR - activated overexpression of MDR1 during acquired multidrug resistant.<h4>Experimental design</h4>Arginine methyltransferase inhibitor 1 (AMI-1) was used to pharmacologically block PRMT1 in resistant breast cancer cells (MCF7/adr). The mRNA and protein levels of MDR1 were detected by real-time PCR and western blotting analysis. Immunofluorescence microscopy and co-immunoprecipitation were used to investigate the physical interaction between PXR an"],"journal":["Oncotarget"],"pagination":["20236-48"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC4991450"],"repository":["biostudies-literature"],"pubmed_title":["Protein arginine methyltransferase 1 may be involved in pregnane x receptor-activated overexpression of multidrug resistance 1 gene during acquired multidrug resistant."],"pmcid":["PMC4991450"],"pubmed_authors":["Liu H","Li T","Xiao Y","Jiang X","Liu P","Kong AN","Ma Z","Wang L"],"additional_accession":[]},"is_claimable":false,"name":"Protein arginine methyltransferase 1 may be involved in pregnane x receptor-activated overexpression of multidrug resistance 1 gene during acquired multidrug resistant.","description":"<h4>Purpose</h4>Pregnane x receptor (PXR) - activated overexpression of the multidrug resistance 1 (MDR1) gene is an important way for tumor cells to acquire drug resistance. However, the detailed mechanism still remains unclear. In the present study, we aimed to investigate whether protein arginine methyl transferase 1(PRMT1) is involved in PXR - activated overexpression of MDR1 during acquired multidrug resistant.<h4>Experimental design</h4>Arginine methyltransferase inhibitor 1 (AMI-1) was used to pharmacologically block PRMT1 in resistant breast cancer cells (MCF7/adr). The mRNA and protein levels of MDR1 were detected by real-time PCR and western blotting analysis. Immunofluorescence microscopy and co-immunoprecipitation were used to investigate the physical interaction between PXR an","dates":{"release":"2016-01-01T00:00:00Z","publication":"2016 Apr","modification":"2025-04-19T17:54:14.309Z","creation":"2019-03-27T02:21:04Z"},"accession":"S-EPMC4991450","cross_references":{"pubmed":["26934120"],"doi":["10.18632/oncotarget.7752"]}}